Sevoflurane reduces leukocyte and platelet adhesion after ischemia-reperfusion by protecting the endothelial glycocalyx

Anesthesiology

Volumn 115, Issue 3, 2011, Pages 483-491

  Chappell, Daniel ^a   Heindl, Bernhard ^a   Jacob, Matthias ^a   Annecke, Thorsten ^a   Chen, Congcong ^a   Rehm, Markus ^a   Conzen, Peter ^a   Becker, Bernhard F ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SEVOFLURANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTALLOID; DRUG ACTIVITY; ELECTRON MICROSCOPY; ENDOTHELIUM; ERYTHROCYTE; GLYCOCALYX; GUINEA PIG; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; ISCHEMIA; LEUKOCYTE; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; THROMBOCYTE ADHESION; VASCULAR ENDOTHELIUM;

EID: 80052162260     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182289988     Document Type: Article

References (52)

1. Girn HR, Ahilathirunayagam S, Mavor AI, Homer-Vanniasinkam S: Reperfusion syndrome: Cellular mechanisms of microvascular dysfunction and potential therapeutic strategies. Vasc Endovascular Surg 2007; 41:277-293 (Pubitemid 47258443)
2. Jordan JE, Zhao ZQ, Vinten-Johansen J: The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999; 43:860-878 (Pubitemid 29413185)
3. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC: Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: Reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997; 87:361-370 (Pubitemid 27435379)
4. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC: Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 1999; 91:1437-1446 (Pubitemid 29506108)
5. Heindl B, Reichle FM, Zahler S, Conzen PF, Becker BF: Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999; 91:521-530 (Pubitemid 29365036)
6. Heindl B, Becker BF, Zahler S, Conzen PF: Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig hearts. Acta Anaesthesiol Scand 1998; 42:995-1003 (Pubitemid 28416872)
7. Cromheecke S, Pepermans V, Hendrickx E, Lorsomradee S, Ten Broecke PW, Stockman BA, Rodrigus IE, De Hert SG: Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 2006; 103:289-296 (Pubitemid 44140622)
8. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE: Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101:299-310 (Pubitemid 38988484)
9. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M: Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003; 98:1315-1327 (Pubitemid 36622462)
10. Lucchinetti E, Ambrosio S, Aguirre J, Herrmann P, Härter L, Keel M, Meier T, Zaugg M: Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology 2007; 106:262-268 (Pubitemid 46185170)
11. Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J, MacAllister R: Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 2001; 103:1624-1630 (Pubitemid 32246608)
12. de Klaver MJ, Buckingham MG, Rich GF: Isoflurane pretreatment has immediate and delayed protective effects against cytokine-induced injury in endothelial and vascular smooth muscle cells. Anesthesiology 2003; 99:896-903 (Pubitemid 37186081)
13. Chappell D, Jacob M, Hofmann-Kiefer K, Bruegger D, Rehm M, Conzen P, Welsch U, Becker BF: Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007; 107:776-784 (Pubitemid 351325970)
14. Chappell D, Jacob M, Becker BF, Hofmann-Kiefer K, Conzen P, Rehm M: [Expedition glycocalyx: A newly discovered "Great Barrier Reef"]. Anaesthesist 2008; 57:959-969
15. Rehm M, Zahler S, Lötsch M, Welsch U, Conzen P, Jacob M, Becker BF: Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004; 100:1211-1223 (Pubitemid 38541978)
16. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES: The endothelial glycocalyx: A potential barrier between health and vascular disease. Curr Opin Lipidol 2005; 16:507-511 (Pubitemid 41376899)
17. Chappell D, Jacob M, Paul O, Rehm M, Welsch U, Stoeckelhuber M, Conzen P, Becker BF: The glycocalyx of the human umbilical vein endothelial cell: An impressive structure ex vivo but not in culture. Circ Res 2009; 104:1313-1317
18. Pries AR, Kuebler WM: Normal endothelium. Handb Exp Pharmacol 2006; 176:1-40
19. Chappell D, Hofmann-Kiefer K, Jacob M, Rehm M, Briegel J, Welsch U, Conzen P, Becker BF: TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 2009; 104:78-89
20. Marechal X, Favory R, Joulin O, Montaigne D, Hassoun S, Decoster B, Zerimech F, Neviere R: Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008; 29:572-576 (Pubitemid 351544076)
21. Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007; 73:575-586 (Pubitemid 46073952)
22. Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M: Therapeutic strategies targeting the endothelial glycocalyx: Acute deficits, but great potential. Cardiovasc Res 2010; 87:300-310
23. Constantinescu AA, Vink H, Spaan JA: Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 2003; 23: 1541-1547 (Pubitemid 37108195)
24. Vink H, Constantinescu AA, Spaan JA: Oxidized lipoproteins degrade the endothelial surface layer: Implications for platelet-endothelial cell adhesion. Circulation 2000; 101:1500-1502 (Pubitemid 30180883)
25. Annecke T, Chappell D, Chen C, Jacob M, Welsch U, Sommerhoff CP, Rehm M, Conzen PF, Becker BF: Sevoflurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury. Br J Anaesth 2010; 104:414-421
26. Skrzypiec-Spring M, Grotthus B, Szelag A, Schulz R: Isolated heart perfusion according to Langendorff: Still viable in the new millennium. J Pharmacol Toxicol Methods 2007; 55: 113-126 (Pubitemid 46227990)
27. Möbert J, Zahler S, Becker BF, Conzen PF: Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. Anesthesiology 1999; 90:1372-1381 (Pubitemid 29205642)
28. Szekely A, Heindl B, Zahler S, Conzen PF, Becker BF: S(-)-ketamine, but not R(-)-ketamine, reduces postischemic adherence of neutrophils in the coronary system of isolated guinea pig hearts. Anesth Analg 1999; 88:1017-1024 (Pubitemid 29211531)
29. Heindl B, Conzen PF, Becker BF: The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts. Basic Res Cardiol 1999; 94:102-111 (Pubitemid 29182384)
30. Vogel J, Sperandio M, Pries AR, Linderkamp O, Gaehtgens P, Kuschinsky W: Influence of the endothelial glycocalyx on cerebral blood flow in mice. J Cereb Blood Flow Metab 2000; 20:1571-1578
31. Menger MD, Rücker M, Vollmar B: Capillary dysfunction in striated muscle ischemia/reperfusion; On the mechanisms of capillary "no- reflow". Shock 1997; 8:2-7 (Pubitemid 127709556)
32. Menger MD, Vollmar B: Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: Is it time for the introduction of pleiotropic compounds? Transplant Proc 2007; 39:485-488 (Pubitemid 46386243)
33. Menger MD, Vollmar B: Adhesion molecules as determinants of disease: From molecular biology to surgical research. Br J Surg 1996; 83:588-601 (Pubitemid 26163543)
34. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136 (Pubitemid 17174962)
35. Kalb R, Schober P, Schwarte LA, Weimann J, Loer SA: Preconditioning, but not postconditioning, with sevoflurane reduces pulmonary neutrophil accumulation after lower body ischaemia/reperfusion injury in rats. Eur J Anaesthesiol 2008; 25:454-459 (Pubitemid 351629962)
36. Weber NC, Frässdorf J, Ratajczak C, Grueber Y, Schlack W, Hollmann MW, Preckel B: Xenon induces late cardiac preconditioning in vivo: A role for cyclooxygenase 2? Anesth Analg 2008; 107:1807-1813
37. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW: Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 2004; 101: 1313-1324 (Pubitemid 39564987)
38. Lee HT, Chen SW, Doetschman TC, Deng C, D'Agati VD, Kim M: Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta1 pathway. Am J Physiol Renal Physiol 2008; 295:F128-136
39. Payne RS, Akca O, Roewer N, Schurr A, Kehl F: Sevofluraneinduced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res 2005; 1034:147-152 (Pubitemid 40248526)
40. Sanada H, Higashi Y, Goto C, Chayama K, Yoshizumi M, Sueda T: Vascular function in patients with lower extremity peripheral arterial disease: A comparison of functions in upper and lower extremities. Atherosclerosis 2005; 178: 179-185 (Pubitemid 39600831)
41. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, Peter K, Becker BF: Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116:1896-1906 (Pubitemid 350287085)
42. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M: Increased levels of glycosaminoglycans during septic shock: Relation to mortality and the antibacterial actions of plasma. Shock 2008; 30:623-627
43. Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, Meijers JC, Holleman F, Hoekstra JB, Vink H, Kastelein JJ, Stroes ES: Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006; 55:480-486 (Pubitemid 43343279)
44. Chappell D, Jacob M, Hofmann-Kiefer K, Rehm M, Welsch U, Conzen P, Becker BF: Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc Res 2009; 83:388-396
45. Kupatt C, Habazettl H, Goedecke A, Wolf DA, Zahler S, Boekstegers P, Kelly RA, Becker BF: Tumor necrosis factoralpha contributes to ischemia-and reperfusion-induced endothelial activation in isolated hearts. Circ Res 1999; 84:392-400 (Pubitemid 29120004)
46. Bruegger D, Rehm M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: Exogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts. Crit Care 2008; 12:R73
47. Jacob M, Rehm M, Loetsch M, Paul JO, Bruegger D, Welsch U, Conzen P, Becker BF: The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated coronary dilatation. J Vasc Res 2007; 44:435-443 (Pubitemid 350022326)
48. Kowalski C, Zahler S, Becker BF, Flaucher A, Conzen PF, Gerlach E, Peter K: Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. Anesthesiology 1997; 86:188-195 (Pubitemid 27044016)
49. Zahler S, Kupatt C, Seligmann C, Kowalski C, Becker BF, Gerlach E: Retention of leucocytes in reperfused, isolated hearts does not cause haemodynamically relevant permanent capillary plugging. Pflugers Arch 1997; 433:713-720 (Pubitemid 27140494)
50. Potter DR, Damiano ER: The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circ Res 2008; 102:770-776 (Pubitemid 351521584)
51. Kupatt C, Zahler S, Seligmann C, Massoudy P, Becker BF, Gerlach E: Nitric oxide mitigates leukocyte adhesion and vascular leak after myocardial ischemia. J Mol Cell Cardiol 1996; 28:643-654 (Pubitemid 26110505)
52. Chlopicki S, Lomnicka M, Gryglewski RJ: Obligatory role of lipid mediators in platelet-neutrophil adhesion. Thromb Res 2003; 110:287-292 (Pubitemid 37329827)